489 related articles for article (PubMed ID: 22261707)
1. Divergent expression of MUC5AC, MUC6, MUC2, CD10, and CDX-2 in dysplasia and intramucosal adenocarcinomas with intestinal and foveolar morphology: is this evidence of distinct gastric and intestinal pathways to carcinogenesis in Barrett Esophagus?
Khor TS; Alfaro EE; Ooi EM; Li Y; Srivastava A; Fujita H; Park Y; Kumarasinghe MP; Lauwers GY
Am J Surg Pathol; 2012 Mar; 36(3):331-42. PubMed ID: 22261707
[TBL] [Abstract][Full Text] [Related]
2. Foveolar type dysplasia in Barrett esophagus.
Brown IS; Whiteman DC; Lauwers GY
Mod Pathol; 2010 Jun; 23(6):834-43. PubMed ID: 20228780
[TBL] [Abstract][Full Text] [Related]
3. Cdx2 expression and its promoter methylation during metaplasia-dysplasia-carcinoma sequence in Barrett's esophagus.
Makita K; Kitazawa R; Semba S; Fujiishi K; Nakagawa M; Haraguchi R; Kitazawa S
World J Gastroenterol; 2013 Jan; 19(4):536-41. PubMed ID: 23382633
[TBL] [Abstract][Full Text] [Related]
4. Adenomatous and foveolar gastric dysplasia: distinct patterns of mucin expression and background intestinal metaplasia.
Park DY; Srivastava A; Kim GH; Mino-Kenudson M; Deshpande V; Zukerberg LR; Song GA; Lauwers GY
Am J Surg Pathol; 2008 Apr; 32(4):524-33. PubMed ID: 18300795
[TBL] [Abstract][Full Text] [Related]
5. Esophageal polypoid dysplasia of gastric foveolar phenotype with focal intramucosal carcinoma associated with Barrett's esophagus.
Asthana N; Mandich D; Ligato S
Am J Surg Pathol; 2008 Oct; 32(10):1581-5. PubMed ID: 18724240
[TBL] [Abstract][Full Text] [Related]
6. CDX2, COX2 and MUC2 expressions in Barrett's esophagus: can they be useful in determination of the dysplasia?
Türkmen IÇ; Başsüllü N; Uraz S; Yerdel MA; Memışoğlu R; Bülbül Doğusoy G
Turk Patoloji Derg; 2012; 28(3):251-8. PubMed ID: 23011828
[TBL] [Abstract][Full Text] [Related]
7. Mucinous phenotype and CD10 expression of primary adenocarcinoma of the small intestine.
Kumagai R; Kohashi K; Takahashi S; Yamamoto H; Hirahashi M; Taguchi K; Nishiyama K; Oda Y
World J Gastroenterol; 2015 Mar; 21(9):2700-10. PubMed ID: 25759539
[TBL] [Abstract][Full Text] [Related]
8. Mucin expression profile in Barrett's, dysplasia, adenocarcinoma sequence in the esophagus.
Burjonrappa SC; Reddimasu S; Nawaz Z; Gao X; Sharma P; Loggie B
Indian J Cancer; 2007; 44(1):1-5. PubMed ID: 17401217
[TBL] [Abstract][Full Text] [Related]
9. Esophageal adenocarcinoma arising in cervical inlet patch with synchronous Barrett's esophagus-related dysplasia.
Tanaka M; Ushiku T; Ikemura M; Shibahara J; Seto Y; Fukayama M
Pathol Int; 2014 Aug; 64(8):397-401. PubMed ID: 25143128
[TBL] [Abstract][Full Text] [Related]
10. Comparing outcome of radiofrequency ablation in Barrett's with high grade dysplasia and intramucosal carcinoma: a prospective multicenter UK registry.
Haidry RJ; Lipman G; Banks MR; Butt MA; Sehgal V; Graham D; Dunn JM; Gupta A; Sweis R; Miah H; Morris D; Smart HL; Bhandari P; Willert R; Fullarton G; Morris J; Di Pietro M; Gordon C; Penman I; Barr H; Patel P; Boger P; Kapoor N; Mahon B; Hoare J; Narayanasamy R; O'Toole D; Cheong E; Direkze NC; Ang Y; Veitch A; Dhar A; Nyalender D; Ragunath K; Leahy A; Fullard M; Rodriguez-Justo M; Novelli M; Lovat LB
Endoscopy; 2015 Nov; 47(11):980-7. PubMed ID: 26126159
[TBL] [Abstract][Full Text] [Related]
11. Low-grade gastric adenomas/dysplasias: phenotypic expression, DNA ploidy pattern, and LOH at microsatellites linked to the APC gene.
Tanaka A; Takemura-Tsukashita S; Kushima R; Sugihara H; Fujiyama Y; Hattori T
Pathol Res Pract; 2008; 204(1):1-9. PubMed ID: 17964080
[TBL] [Abstract][Full Text] [Related]
12. Mucin expression and proliferating cell index of esophageal Barrett's adenocarcinoma.
Yamamoto S; Kijima H; Hara T; Chino O; Shimada H; Tanaka M; Inokuchi S; Makuuchi H
Int J Mol Med; 2005 Sep; 16(3):375-80. PubMed ID: 16077942
[TBL] [Abstract][Full Text] [Related]
13. Esophageal dysplasia and adenocarcinoma: a study with double immunostaining for intestinal and gastric markers.
Chlumská A; Mukenšnabl P; Waloschek T; Zámečník M
Cesk Patol; 2018; 54(2):81-85. PubMed ID: 30441967
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic differences between esophageal and gastric intestinal metaplasia.
Piazuelo MB; Haque S; Delgado A; Du JX; Rodriguez F; Correa P
Mod Pathol; 2004 Jan; 17(1):62-74. PubMed ID: 14631367
[TBL] [Abstract][Full Text] [Related]
15. Magnifying endoscopy of gastric epithelial dysplasia based on the morphologic characteristics.
Kang HM; Kim GH; Park DY; Cheong HR; Baek DH; Lee BE; Song GA
World J Gastroenterol; 2014 Nov; 20(42):15771-9. PubMed ID: 25400462
[TBL] [Abstract][Full Text] [Related]
16. The diagnosis and management of Barrett's esophagus.
DeMeester SR; DeMeester TR
Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
[TBL] [Abstract][Full Text] [Related]
17. Pyloric gland adenoma: an entity distinct from gastric foveolar type adenoma.
Chen ZM; Scudiere JR; Abraham SC; Montgomery E
Am J Surg Pathol; 2009 Feb; 33(2):186-93. PubMed ID: 18830123
[TBL] [Abstract][Full Text] [Related]
18. Trefoil Factor Expression in a Human Model of the Early Stages of Barrett's Esophagus.
Dunn LJ; Jankowski JA; Griffin SM
Dig Dis Sci; 2015 May; 60(5):1187-94. PubMed ID: 25424203
[TBL] [Abstract][Full Text] [Related]
19. Re-evaluation of phenotypic expression in undifferentiated-type early gastric adenocarcinomas using mucin core protein and CDX2.
Ikarashi S; Nishikura K; Ajioka Y; Aoyagi Y
Gastric Cancer; 2013 Apr; 16(2):208-19. PubMed ID: 22829163
[TBL] [Abstract][Full Text] [Related]
20. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
